home / stock / esalf / esalf news


ESALF News and Press, Eisai Co Ltd From 04/16/24

Stock Information

Company Name: Eisai Co Ltd
Stock Symbol: ESALF
Market: OTC

Menu

ESALF ESALF Quote ESALF Short ESALF News ESALF Articles ESALF Message Board
Get ESALF Alerts

News, Short Squeeze, Breakout and More Instantly...

ESALF - Biogen's Alzheimer's drug to cost $3.5B for Medicare in 2025: report

2024-04-16 15:31:20 ET More on Biogen, Eisai, etc. Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Eisai: All About Lenvima And Leqembi Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) GLP-1s benefit Parkinson’...

ESALF - French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics TOKYO, Apr 3, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the ...

ESALF - Eisai submits sBLA for monthly maintenance dose of Alzheimer's drug Leqembi

2024-04-01 06:04:15 ET More on Biogen, Eisai Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Eisai: All About Lenvima And Leqembi Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) EU delays decision on Eisai-Biogen Alz...

ESALF - Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA

Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. annou...

ESALF - Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical

Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name:...

ESALF - Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024

Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024 TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that drug discovery research conducted on lemborexant (brand name: Dayvigo), ...

ESALF - Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture

Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that "NouKNOW", Eisai's self-check tool for brain health, was certified as a "ME-BYO BRAND" by Kanagawa prefect...

ESALF - EU delays decision on Eisai-Biogen Alzheimer's drug

2024-03-22 08:50:49 ET More on Biogen, Eisai Co., Ltd., etc. Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Eisai: All About Lenvima And Leqembi Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen chief medical o...

ESALF - Lifenet and Eisai Co-Develop Dementia Insurance "be"

Lifenet and Eisai Co-Develop Dementia Insurance "be" TOKYO, Mar 21, 2024 - (JCN Newswire) - LIFENET INSURANCE COMPANY and Eisai Co., Ltd. announced today that they have co-developed Dementia Insurance "be", a dementia insurance that supports early detection and treatment of dementia...

ESALF - Eisai Selected as a Nadeshiko Brand 2024 as a Listed Company Excelling in Promotion of Women in the Workplace

Eisai Selected as a Nadeshiko Brand 2024 as a Listed Company Excelling in Promotion of Women in the Workplace TOKYO, Mar 21, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been selected for the first time by the Ministry of Economy, Trade and Industry (METI) and...

Previous 10 Next 10